» Articles » PMID: 15609223

How Soon After Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold Miners

Overview
Journal J Infect Dis
Date 2004 Dec 21
PMID 15609223
Citations 179
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Infection with human immunodeficiency virus (HIV) increases the risk of tuberculosis (TB), but no study has assessed how this risk changes with time since HIV seroconversion.

Methods: The incidence of pulmonary TB was estimated in miners with and those without HIV infection in a retrospective cohort study. HIV test results were linked to routinely collected TB, demographic, and occupational data. The rate ratio (RR) for the association between HIV status and TB was estimated by time since HIV seroconversion, calendar period, and age.

Results: Of the 23,874 miners in the cohort, 17,766 were HIV negative on entry, 3371 were HIV positive on entry, and 2737 seroconverted during follow-up (1962 had a seroconversion interval of < or =2 years). A total of 740 cases of TB were analyzed. The incidence of TB increased with time since seroconversion, calendar period, and age. TB incidence was 2.90 cases/100 person-years at risk (pyar) in HIV-positive miners and was 0.80 cases/100 pyar in HIV-negative miners (adjusted RR, 2.9 [95% confidence interval {CI}, 2.5-3.4]). TB incidence doubled within the first year of HIV infection (adjusted RR, 2.1 [95% CI, 1.4-3.1]), with a further slight increase in HIV-positive miners for longer periods, up to 7 years.

Conclusion: The increase in the risk of TB so soon after infection with HIV was unexpected. Current predictive models of TB incidence underestimate the effect of HIV infection in areas where TB is endemic.

Citing Articles

Specific immune response to and ability to control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection.

Farroni C, Altera A, Salmi A, Vanini V, Cuzzi G, Arlehamn C Front Immunol. 2025; 15:1484143.

PMID: 39872515 PMC: 11770028. DOI: 10.3389/fimmu.2024.1484143.


Incidence Rate and Risk Factors for Developing Active Tuberculosis Among People Living With HIV in Georgia 2019-2020 Cohort.

Buziashvili M, Djibuti M, Tukvadze N, DeHovitz J, Baliashvili D Open Forum Infect Dis. 2024; 11(9):ofae466.

PMID: 39257676 PMC: 11384916. DOI: 10.1093/ofid/ofae466.


Unmasking the hidden impact of viruses on tuberculosis risk.

Darboe F, Reijneveld J, Maison D, Martinez L, Suliman S Trends Immunol. 2024; 45(9):649-661.

PMID: 39181733 PMC: 11769684. DOI: 10.1016/j.it.2024.07.008.


Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection.

Singh B, Sharan R, Ravichandran G, Escobedo R, Shivanna V, Dick Jr E JCI Insight. 2024; 9(15).

PMID: 39114981 PMC: 11383603. DOI: 10.1172/jci.insight.179317.


Role of Type I Interferons during and HIV Infections.

Anes E, Azevedo-Pereira J, Pires D Biomolecules. 2024; 14(7).

PMID: 39062562 PMC: 11275242. DOI: 10.3390/biom14070848.